Abstract
Intravascular devices (IVDs) are widely used in modern day health care. Unfortunately, their use is associated with substantial risk of bloodstream infection (BSI) and sepsis, with increased hospitalization and hospital mortality. IVDs are the most common cause of nosocomial BSI. The wider use of new methodologies for diagnosis of IVD-related infection should allow earlier and more focused therapy and, especially, improve the accuracy of surveillance. Of all nosocomial infections, IVD-related BSIs are most amendable to prevention.
Similar content being viewed by others
References and Recommended Reading
Maki D, Mermel L: Infections due to infusion therapy. In Hospital Infections, edn 4. Edited by Bennett JV, Brachman PS. Philadelphia: Lippincott-Raven; 1998:689–724. A comprehensive, exhaustively referenced review of all aspects of IVDR infection, including pathogenesis, epidemiology, prevention, and management.
Mermel LA: Prevention of intravascular catheter-related infections. Ann Intern Med 2000, 132:391–402. A scholarly analysis of the scientific evidence underlying different strategies for prevention of IVDR BSI.
Maki DG, Stolz SS, Wheeler S, Mermel LA: A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1994, 22:1729–1737.
Maki DG, Stolz SM, Wheeler S, Mermel LA: Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997, 127:257–266. The first and largest prospective randomized trial of the chlorhexidine-silver sulfadiazine-impregnated CVC, which used molecular subtyping. Provides insight into the pathogenesis of short-term CVCrelated BSI and the role of IVDs in nosocomial BSI.
Cheesbrough JS, Finch RG, Burden RP: A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis 1986, 154:579–589.
Weightman NC, Simpson EM, Speller DC, et al.: Bacteraemia related to indwelling central venous catheters: prevention, diagnosis and treatment. Eur J Clin Microbiol Infect Dis 1988, 7:125–129.
Maki DG, Narans LL, Banton J: A prospective study of the pathogenesis of picc-related bsi [abstract]. Paper presented at Proceedings and Abstracts of the 38th Interscience Conference of Antimicrobial Agents and Chemotherapy. San Diego. September 24–27, 1998.
Garner JS, Jarvis WR, Emori TG, et al.: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128–140.
Raad I, Darouiche R, Dupuis J, et al.: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997, 127:267–274. A large, multicenter trial of 865 catheters, which showed that the minocycline-rifampin-coated CVC was superior to the chlorhexidinesilver sulfadiazine-impregnated catheter for prevention of CVCrelated BSI.
Bone RC, Balk RA, Cerra FB, et al.: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644–1655.
Rangel-Frausto MS, Pittet D, Costigan M, et al.: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117–123.
Balk RA: Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clin 2000, 16:179–192.
Martin MA, Pfaller MA, Wenzel RP: Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989, 110:9–16.
Riebel W, Frantz N, Adelstein D, Spagnuolo PJ: Corynebacterium JK: a cause of nosocomial device-related infection. Rev Infect Dis 1986, 8:42–49.
Banerjee C, Bustamante CI, Wharton R, et al.: Bacillus infections in patients with cancer. Arch Intern Med 1988, 148:1769–1774.
Pittet D, Li N, Woolson R, Wenzel R: Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997, 24:1068–1078.
Opal SM, Cross AS: Clinical trials for severe sepsis. Past failures, and future hopes. Infect Dis Clin North Am 1999, 13:285–297. A scholarly review of the novel therapies for sepsis that have been examined in clinical trials over the past 25 years.
Kluger D, Maki D: The relative risk of intravascular devicerelated bloodstream infections with different types of intravascular devices in adults. A meta-analysis of 206 published studies. Paper presented at the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections. Atlanta. March 5–9, 2000.
Angus DC, Linde-Zwirble WT, Lidicker J, et al.: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303–1310. A current analysis highlighting the societal burden and economic cost of sepsis in the United States.
O’Grady NP, Barie PS, Bartlett J, et al.: Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med 1998, 26:392–408. An evidence-based guideline providing recommendations for the evaluation of patients in the intensive care unit with fever or other signs suggestive of infection.
Mermel LA, Farr BM, Sherertz RJ, et al.: Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001, 32:1249–1272. A comprehensive evidence-based guideline for the evaluation and treatment of intravascular catheter-related infections.
Kristinsson KG, Burnett IA, Spencer RC: Evaluation of three methods for culturing long intravascular catheters. J Hosp Infect 1989, 14:183–191.
Sherertz RJ, Heard SO, Raad II: Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997, 35:641–646.
Siegman-Igra Y, Anglim AM, Shapiro DE, et al.: Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997, 35:928–936. A scholarly analysis of qualitative, semiquantitative, and quantitative culture methods of blood and catheter segments from 22 published studies. A single unpaired quantitative blood culture drawn from a long-term IVD is shown to be viable and a cost-effective method for diagnosing IVDR BSI.
Pfaller MA: Molecular epidemiology in the care of patients. Arch Pathol Lab Med 1999, 123:1007–1010. A succinct and excellent review of molecular techniques available for epidemiologic studies and their role in patient care and research.
Gowardman JR, Montgomery C, Thirlwell S, et al.: Central venous catheter-related bloodstream infections: an analysis of incidence and risk factors in a cohort of 400 patients. Intensive Care Med 1998, 24:1034–1039. A study of triple-lumen CVCs, comprising more than 3000 IVD-days, that demonstrated poor utility of AOLC staining for the diagnosis of IVDR BSI with short-term IVDs: it failed to identify all 12 documented catheter-related BSIs.
Tacconelli E, Tumbarello M, Pittiruti M, et al.: Central venous catheter-related sepsis in a cohort of 366 hospitalized patients. Eur J Clin Microbiol Infect Dis 1997, 16:203–209.
Capdevila JA, Planes AM, Palomar M, et al.: Value of differential quantitative blood cultures in the diagnosis of catheterrelated sepsis. Eur J Clin Microbiol Infect Dis 1992, 11:403–407.
Douard MC, Arlet G, Longuet P, et al.: Diagnosis of venous access port-related infections. Clin Infect Dis 1999, 29:1197–1202.
Telenti A, Steckelberg JM, Stockman L, et al.: Quantitative blood cultures in candidemia. Mayo Clin Proc 1991, 66:1120–1123.
Douard MC, Arlet G, Leverger G, et al.: Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med 1991, 17:30–35.
Sherertz RJ, Raad, II, Belani A, et al.: Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990, 28:76–82.
Blot F, Nitenberg G, Chachaty E, et al.: Diagnosis of catheterrelated bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999, 354:1071–1077. A well-designed prospective study of a novel application of the continuously monitored blood culture system that shows that detection of growth in a blood culture drawn through an IVD 120 minutes or more before detection of growth in a peripherally-drawn blood culture is highly predictive of an infected IVD: 16 of 17 documented IVDR BSIs from long-term IVDs were correctly identified.
Mermel LA, Josephson S, Binns L: Diagnosis of catheterrelated bloodstream infection (CRBSI) by differential growth rates of catheter-drawn and percutaneously drawn blood cultures [abstract]. Paper presented at Programs and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego. September 24–27, 1998.
Rijnders BJ, Verwaest C, Peetermans WE, et al.: Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients. Crit Care Med 2001, 29:1399–1403.
Kite P, Dobbins BM, Wilcox MH, McMahon MJ: Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet 1999, 354:1504–1507. A study of 128 suspected cases of IVDR BSI, with IVDs in place for an average of 16 days, in which the AOLC test combined with Gram staining was shown to be 96% sensitive and have a positive predictive value of 91%.
Rushforth JA, Hoy CM, Kite P, Puntis JW: Rapid diagnosis of central venous catheter sepsis. Lancet 1993, 342:402–403.
Kite P, Dobbins BM, Wilcox MH, et al.: Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter related sepsis. J Clin Pathol 1997, 50:278–282.
van Heerden PV, Webb SA, Fong S, et al.: Central venous catheters revisited--infection rates and an assessment of the new Fibrin Analysing System brush. Anaesth Intensive Care 1996, 24:330–333.
Seo SK, Venkataraman L, DeGirolami PC, Samore MH: Molecular typing of coagulase-negative staphylococci from blood cultures does not correlate with clinical criteria for true bacteremia. Am J Med 2000, 109:697–704. A recent study of 42 patients with multiple blood cultures positive for CNS, which found that clinical criteria for identifying a "significant" bacteremia correlated with molecular testing in only 12 of 23 patients. In contrast, eight of 19 patients considered to have contaminated blood cultures by clinical criteria really had true bacteremia, based on molecular techniques showing genetic identity of multiple blood isolates.
McGregor AR, Collignon PJ: Bacteraemia and fungaemia in an Australian general hospital--associations and outcomes. Med J Aust 1993, 158:671–674.
Rello J, Ricart M, Mirelis B, et al.: Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 1994, 20:94–98.
Valles J, Leon C, Alvarez-Lerma F: Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis 1997, 24:387–395.
Garrouste-Orgeas M, Chevret S, Mainardi JL, et al.: A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome. J Hosp Infect 2000, 44:206–213.
Lark RL, Chenoweth C, Saint S, et al.: Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 2000, 38:131–140.
Jensen AG, Wachmann CH, Poulsen KB, et al.: Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med 1999, 159:1437–1444.
Farinas-Alvarez C, Farinas MC, Fernandez-Mazarrasa C, et al.:Epidemiological differences between sepsis syndrome with bacteremia and culture-negative sepsis. Infect Control Hosp Epidemiol 2000, 21:639–644.
Blumberg HM, Jarvis WR, Soucie JM, et al.: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001, 33:177–186.
Wey SB, Mori M, Pfaller MA, et al.: Risk factors for hospitalacquired candidemia. A matched case-control study. Arch Intern Med 1989, 149:2349–2353.
Mylotte JM, McDermott C, Spooner JA: Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987, 9:891–907.
Centers for Disease Control: Monitoring hospital-acquired infections to promote patient safety-United States, 1990–1999. MMWR 2000, 49:149–153. A very encouraging report recently released by the CDC showing a 40% decline in the rate of central line-associated BSIs in NNIS hospitals over the past decade.
Pittet D, Li N, Wenzel RP: Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur J Clin Microbiol Infect Dis 1993, 12:813–819.
Rello J, Ochagavia A, Sabanes E, et al.: Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000, 162:1027–1030.
Pittet D, Tarara D, Wenzel R: Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271:1598–1601.
Freeman J, Epstein MF, Smith NE, et al.: Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations. Am J Dis Child 1990, 144:324–329.
Dimick JB, Pelz RK, Consunji R, et al.: Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001, 136:229–234. A study in 260 surgical patients that demonstrated that IVDR BSI was associated with an increased length of stay of 22 days and an incremental cost of health care of $56,000.
Arnow PM, Quimosing EM, Beach M: Consequences of intravascular catheter sepsis. Clin Infect Dis 1993, 16:778–784.
Collignon PJ: Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994, 161:374–378.
Anaissie EJ, Rex JH, Uzun O, Vartivarian S: Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998, 104:238–245.
Maki DG, Agger A: Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine 1988, 67:248–269.
Capell S, Linares J, Sitges-Serra A: Catheter sepsis due to coagulase-negative staphylococci in patients on total parenteral nutrition. Eur J Clin Microbiol 1986, 5:40–42.
Ibrahim EH, Sherman G, Ward S, et al.: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146–155. An important, recent, prospective study of 492 BSIs in patients admitted to the intensive care units of Washington University Medical Center that showed that the adequacy of the initial antimicrobial regimen was the most important determinant of outcome, even when adjusting for severity of illness: mortality among patients whose initial regimen was considered inadequate was 62%, in contrast with 32% in patients whose initial regimen was considered adequate.
Raad I, Davis S, Khan A, et al.: Impact of central venous catheter removal on the recurrence of catheter-related coagulasenegative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992, 13:215–221.
Malanoski GJ, Samore MH, Pefanis A, Karchmer AW: Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995, 155:1161–1166.
Rex JH, Bennett JE, Sugar AM, et al.: Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis 1995, 21:994–996.
Elting LS, Bodey GP: Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine 1990, 69:296–306.
Mermel LA: New technologies to prevent intravascular catheter-related bloodstream infections. Emerg Infect Dis 2001, 7:197–199.
Crnich CJ, Maki DG: The promise of novel technology for prevention of intravascular device-related bloodstream infection. Clin Infect Dis 2001, In press. An in-depth review of all of the published clinical trials evaluating the benefit of the various novel technologies for the prevention of IVDR BSI.
Pearson ML: Guideline for prevention of intravascular devicerelated infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996, 17:438–473.
O’Grady NP, Alexander M, Bellinger EP, et al.: HICPAC guideline for the prevention of intravascular catheter-related infection. Federal Register 2001, In press. A current, evidence-based guideline that makes recommendations for prevention of IVDR infection with all types of IVDs.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crnich, C.J., Maki, D.G. The role of intravascular devices in sepsis. Curr Infect Dis Rep 3, 496–506 (2001). https://doi.org/10.1007/s11908-001-0086-4
Issue Date:
DOI: https://doi.org/10.1007/s11908-001-0086-4